GlassScriptPhysician profile
Jay Amin
NPI 1881121184
$10,683.49
in general payments reported to CMS, 2019-2025
27 companies · $4,559 in 2025
The $4,559 reported for 2025 was more than what 90% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $995 · 2023: $4,059 · 2024: $1,070 · 2025: $4,559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,774 · Travel and Lodging: $2,474 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,774.48 |
| Travel and Lodging | $2,473.53 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,440.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,806.95 | 2022-2025 | Lumenis Pulse 120h, Lithovue, Moses |
| Axonics, INC. | $1,760.15 | 2022-2024 | Axonics |
| Medtronic, INC. | $1,088.33 | 2025 | Interstim |
| Coloplast Corp | $787.21 | 2022-2025 | Titan |
| Abbvie INC. | $164.89 | 2022-2025 | Botox, Lupron Depot |
| Antares Pharma, INC. | $125.00 | 2022 | |
| Merck Sharp & Dohme LLC | $99.57 | 2022-2023 | Keytruda, Lynparza |
| Sumitomo Pharma America, INC. | $98.03 | 2023-2025 | Gemtesa |
| Teleflex LLC | $96.72 | 2022-2025 | Barrigel, Urolift |
| Calyxo, INC. | $95.57 | 2024 | Cvac Aspiration System |
| Procept Biorobotics Corporation | $77.96 | 2025 | |
| Ferring Pharmaceuticals INC. | $60.06 | 2024-2025 | Adstiladrin |
| Bluewind Medical | $56.61 | 2024 | Revi |
| Pfizer INC. | $46.81 | 2024-2025 | |
| Janssen Scientific Affairs, LLC | $44.40 | 2025 | Pipeline, Erleada |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $33.62 | 2023 | |
| Becton, Dickinson and Company | $31.89 | 2025 | Magic3 Go Intermittent Urinary Catheter |
| Tolmar, INC. | $29.03 | 2025 | Eligard, Jatenzo |
| Photocure INC | $27.76 | 2025 | Cysview |
| Ambu INC. | $26.18 | 2025 | |
| Astellas Pharma US INC | $23.10 | 2023 | Myrbetriq |
| Olympus America INC. | $22.35 | 2024 | Itind System |
| Urovant Sciences INC | $21.76 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $19.55 | 2022 | |
| Medical Device Business Services, INC. | $17.04 | 2022 | |
| Profound Medical Corp. | $15.33 | 2022 | |
| Valencia Technologies Corporation | $7.62 | 2025 | Ecoin Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Amin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.